Processa Pharmaceuticals, Inc. Annual report pursuant to Section 13 and 15(d)

Intangible Assets - Summary of Intangible Assets (Details) - USD ($)	Dec. 31, 2019	Dec. 31, 2018
Gross intangible assets	$ 11,059,429	$ 11,059,429
Less: Accumulated amortization	(1,416,975)	(621,647)
Total intangible assets, net	9,642,454	10,437,782
License Rights To PCS 499 [Member]
Gross intangible assets	11,038,929	11,038,929
Less: Accumulated amortization	(1,405,301)	(616,807)
Total intangible assets, net	9,633,628	10,422,122
Software License [Member]
Gross intangible assets	20,500	20,500
Less: Accumulated amortization	(11,674)	(4,840)
Total intangible assets, net	$ 8,826	$ 15,660